US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Mar 22, 2023 (3 years ago)

Alprazolam C-IV

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

What was recalled

Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534.

Recalling firm
Direct Rx
NDC code
72189-213-30
Origin
GA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0508-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Alprazolam recalls

See all
Class II · Moderate risk Ongoing

Xanax XR

Reason Failed Dissolution Specifications

Viatris, Inc. NDC 58151-506-91 D-0444-2026
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7596-3 D-0506-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7595-3 D-0505-2023
Class II · Moderate risk Terminated

Alprazolam Tab

Reason CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Preferred Pharmaceuticals, Inc. NDC 68788-7594-3 D-0504-2023
Class II · Moderate risk Ongoing

Alprazolam C-IV

Reason CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

Direct Rx NDC 72189-121-60 D-0509-2023